Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) 2021-01-22 02:25
Envirotainer Opens First RAP e2 Station in Taipei 2021-01-21 16:14
Merck Announces Update on the INTR@PID Clinical Program Including Lung 037 Study 2021-01-20 23:35
Clarivate Enhances Cortellis CMC Intelligence Platform with Addition of Comprehensive Biologics Content 2021-01-20 16:15
Innovent Announces an Out-license Agreement with PT Etana Biotechnologies Indonesia to Launch BYVASDA® (Bevacizumab Biosimilar) in Indonesia 2021-01-19 08:00
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy 2021-01-18 19:00
Everest Medicines Announces Amended Agreement with Spero Therapeutics 2021-01-18 18:05
Modern Chinese Medicine Group Co., Ltd. announces its subscription results 2021-01-14 14:30
Ascentage Pharma Presents Updates on its Global Clinical Development at the J.P. Morgan 39th Annual Healthcare Conference 2021-01-14 09:32
Hanmi presents solution package for coping with COVID-19, including the mass production of nucleic acid vaccines (DNA/mRNA vaccine) 2021-01-13 09:00
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab injection) as First-Line Therapy in Hepatocellular Carcinoma (HCC) 2021-01-13 08:00
Kira Pharmaceuticals to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-12 22:57
Beactica Therapeutics and University of Dundee announce collaboration to develop WRN inhibitors to target cancer 2021-01-12 17:26
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs 2021-01-12 12:26
Gannex Announces Positive Phase I Clinical Results on Its THR-β Agonist ASC41 2021-01-12 08:30
MedSkin Solutions Dr. Suwelack AG Receives FDA 510(k) Clearance for MatriDerm® - Its Three-Dimensional Acellular Collagen Elastin Dermal Matrix Portfolio 2021-01-12 04:38
Regent Pacific Announces Key Research Findings On FORTACIN™ 2021-01-11 23:36
Pivotal phase III clinical trial IND submission of the original innovative anticancer drug Chiauranib for the treatment of small cell lung cancer was accepted by the Center of Drug Evaluation of the NMPA. 2021-01-11 11:33
Antengene to Present at the 39th Annual J.P. Morgan Healthcare Conference 2021-01-11 07:26
Kintor's Proxalutamide (GT0918) COVID-19 Clinical Trial Shows Positive Preliminary Results in Treatment of Female Patients 2021-01-10 16:55
1 137 138 139 140 141 234